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Abstract To evaluate the biocompatibility of subretinal
implanted parylene-based Ti/Pt microelectrode arrays
(MEA). Eyes were enucleated 3 months after MEAs were
implanted into the subretinal space of rabbits. Morpholog-
ical changes of the retinas were investigated by H&E
staining. Immunohistochemical staining for glial fibrillary
acidic protein and opsin were performed to evaluate
changes in Muller cells and photoreceptors in the retinas.
Retina tissue around the array remained intact. Photorecep-
tor degeneration and glial cell activation were observed in
the retina overlaying the MEA implant. However, the cells
in the inner retinal layers were preserved. Photoreceptor
degeneration and glial cell activation at the MEA–retina
interface are expected to be a normal reaction to implan-
tation. Material used in this experiment has good biocom-
patibility within the subretinal environment and is expected
to be promising in the further retinal prosthesis studies.
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Introduction
Retinitis pigmentosa and age-related macular degeneration
are the leading retinal degeneration diseases that cause legal
blindness in the world. The common characteristic of these
degeneration diseases is degeneration of photoreceptors
while leaving the inner retina intact. The intact inner retina
provides opportunities for retinal prosthetics to restore
vision through stimulating ganglion cells.
A nontoxic, stable and biocompatible substrate of
microelectrode arrays (MEAs) is required for long-term
usage. Compared with other widely used microfabrication
materials, such as PDMS (polydimethylsiloxane), poly-
imide and silicon, parylene has good biocompatibility,
outstanding moisture barrier properties, low Young’s
modulus, excellent chemical inertia and extremely high
dielectric strength [1]. Parylene coating has good conform-
ability and can be easily patterned by O2 enrolled etching
process [2]. In summary, parylene is a good candidate in the
applications of implantable biomedical microdevices.
There are generally two ways to introduce the array to the
eye, one is through subretinal implantation, while the other is
epi-retinal implantation. There are advantages and disadvan-
tages to the different surgeries. Epiretinal devices can be
relatively large and incorporate sophisticated powering and
data transmission schemes [3], while the subretinal implant
has the theoretical advantage of being placed closer to the
nearest layer of surviving neurons, the bipolar cells [4].
In this study, a flexible microelectrode array on parylene
has been developed and introduced for subretinal stimulation.
Flexible microelectrodes are more suitable for intimate
attachment to the overlying retina as compared to rigid
microelectrodes and epiretinal implants. We evaluated the
long-term biocompatibility of a Ti/Pt retinal prosthetic device
3 months after insertion into the subretinal space of rabbits.
Materials and methods
Surgery procedure
All animal procedures were approved by the Hospital Animal
Care and Use Committee and followed the ARVO Resolution
onthe Use ofAnimals inOphthalmicand Vision use.Flexible
parylene-based MEAs were developed and provided by
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implantedintothesubretinalspace.Threerabbitswereusedin
this study. The experiment was conducted as follows: After
anesthesia,inferiorconjunctiva wasincisedandinferiorrectus
was dissected to expose inferior sclera. A scleratomy was
made 8 mm from the limbus. Intraocular pressure was
decreased via paracentesis. A retina detachment inferior to
the optic disc was made with viscoelastic through a pars plana
incision. A careful cut was made through the choroid and
through the sclerotomy until viscoelastic came out. Then, the
1-mm width MEA chip was inserted into the subretinal space
3 mm inferior to the optic papilla and fixed to the sclera by
suture. The tail of MEA strip was scrolled and embedded
under the conjunctiva.
Tissue preparation
After 3 months of the MEA implantation, the eyes were
enucleated under deep anesthesia to prevent artificial post-
mortem ischemic changes. A mark was made at the sclera
side under which the implant was located. The eyes were
placed in 10% neutral formaldehyde for 24 h. To avoid
disruption artifacts when sectioning the electrode array with
conventional microtomes, the implant was gently removed
from the retina. The eyes were prepared, serially dehy-
drated, embedded in paraffin, and cut into 5-μm specimens
for hematoxylin–eosin staining (H&E staining) and immu-
nohistochemistry studies.
Morphological evaluation and immunohistochemistry
staining
All incubation steps were performed at room temperature.
Paraffin was removed by immersing the slides in xylene.
Tissue was rehydrated through a graded series of alcohol.
Sections were rinsed with 10 mM phosphate-buffered saline
(PBS), pH 7.2, blocked by 5% normal goat serum for 30 min,
and then put in 0.1% Triton X-100 in 10 mM PBS for 10 min.
Sections were incubated with different primary antibodies for
1 h. Primary antibodies used in the present studies are mouse
anti-rabbit monoclonal anti-glial fibrillary acidic protein
(GFAP) (Abcam, 1:400 dilution) and mouse anti-rabbit
monoclonal anti-Opsin (Sigma, 1:1,000 dilution). A second-
ary antibody, FITC-conjugated goat anti-mouse immunoglo-
bulins (Invitrogen, 1:100 dilution), was applied to each
section for 30 min. A Hoechst stain (1:1,000 dilution) was
applied to the sections for 1 min to counterstain nuclei.
Results
H&E staining showed that the outer retina layer directly
overlying the implant changed to a disorganized structure.
Disorganization and breaks in the RPE layer were also
observed. The inner retina and underlying choroid remained
intact (Fig. 1).
To further investigate the changes on different retinal cell
types caused by the MEA implantation, immunofluores-
cence staining was performed. GFAP-labeled cells were
found overlying the MEA with very strong staining
(Fig. 2a) compared to normal distant retina (Fig. 2b),
suggesting occurrence of a glial cell activation related to
inflammatory reactions to MEA. Opsin-positive-labeled
cells were distributed sporadically above the GFAP-
labeled cells in the retinal area above the MEA implantation
(Fig. 3a), while in the retinal area distant to the MEA they
appeared normal (Fig. 3b), suggesting degeneration of
photoreceptors overlying the MEA.
Discussion
Maintenance of the integrity of the inner retina in the
presence of the implants and their electrical activity are
important for the effect of subretinal implantation with
electrode arrays in individuals with photoreceptor degener-
Fig. 1 Hematoxylin and eosin staining of retina overlying MEA.
MEA location is indicated by asterisk in the subretinal space. Retina
overlying the implant is disorganized. Disorganization and disconti-
nuities in the RPE were observed (arrow). Final magnification, ×100
34 j ocul biol dis inform (2009) 2:33–36ation. In our study, the retina overlying the implant showed
disorganization of architecture and photoreceptor degener-
ation. These changes also observed in previous subretina
implanting studies [5, 6]. In the study of cat subretina
microphotodiode array implantation [1], intensity of several
selected metabolic indicators was also changed concomi-
tantly. RPE disorganization and discontinuities could be
caused by almost unavoidable physical damage to RPE
during the surgery process especially when pushing the
array forward under the focal detached retina. RPE damage
demonstrated the breakdown of the blood–retina barrier.
However, the underlying array damage does not signifi-
cantly affect signal transportation in this device.
Glial cells play an important role in response to various
retina insults, including injury, retina detachment, and
photoreceptor degeneration [7–12]. In our study, the glial
cell processes surrounding the implant in the subretinal
space was detected by immunofluorescence. Increased
GFAP labeling suggests the activation of glial cells
overlaying the implant following the implantation surgery
and this may be an inflammatory reaction to MEA.
According to our results, the disorganization, photore-
ceptor degeneration, and the activation of glial cells could
be caused by retina insults including direct operation injury,
retina detachment, and blockage of choroidal nutrients to
the outer retina. Artificial retinal detachment caused by
electrode assay implanting is inevitable in surgical manip-
ulations. Persistent retina detachment leads to a loss of
photoreceptors, a decrease in the thickness of retina in cats
and widespread, multilayered degeneration in rabbits [13,
14]. Choroidal nutrients are the major resource to the outer
retina nutrition. Defects of nutrients for overlying photo-
receptors and inflammation reaction to MEA lead to glial
cell activation, photoreceptor degeneration and result in a
disruption of normal retina structure. However, these
changes only occur in the area immediately overlying
MEA, leaving areas distant to the MEA intact. In retinitis
pigmentosa patients, the degeneration of photoreceptors
Fig. 2 a GFAP-labeled cells in
retina overlaying the implant
(arrows). Asterisk indicates the
implantation location. b GFAP
immunofluorescence labeling of
retina distant to MEA. GFAP
(green); nuclei (blue). Final
magnification, ×100
Fig. 3 a Opsin immunofluorescence labeling of retina overlaying the
implant. Opsin is a characteristic protein in photoreceptors. The image
shows a dispersed distribution of the Opsin labeled cells (arrows),
with a decreased density. Asterisk denotes the implantation location. b
Opsin immunofluorescence labeling of retina distant to MEA. Opsin is
labeled by FITC: fluorescence green; nuclei is stained by Hochest:
fluorescence blue. Final magnification, ×100
j ocul biol dis inform (2009) 2:33–36 35occurs while the inner retina preserved. We suggest that
retinitis pigmentosa patients are good candidates for MEA
implantation.
Parylene has been suggested as a suitable encapsulation
material for retinal prostheses [6, 15]. In our study, incited
tissue reactions and fibrosis did not occur around the
implant by the end of observation period, indicating a stable
biocompatibility of parylene-based Ti/Pt microelectrode
arrays. These results show that the material used in the
experiment has good biocompatibility within the subretinal
environment in the rabbit eye and are promising tools for
use in retinal prosthesis studies in future.
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